Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 49548 | 26.6 |
09:34 ET | 5617 | 26.55 |
09:36 ET | 2000 | 26.58 |
09:38 ET | 10400 | 26.56 |
09:39 ET | 4138 | 26.57 |
09:41 ET | 7205 | 26.65 |
09:43 ET | 3200 | 26.66 |
09:45 ET | 5624 | 26.67 |
09:48 ET | 9005 | 26.77 |
09:50 ET | 2951 | 26.82 |
09:52 ET | 19560 | 26.79 |
09:54 ET | 5515 | 26.78 |
09:56 ET | 3943 | 26.81 |
09:57 ET | 15587 | 26.84 |
09:59 ET | 5561 | 26.79 |
10:01 ET | 3847 | 26.79 |
10:03 ET | 3325 | 26.73 |
10:06 ET | 7587 | 26.74 |
10:08 ET | 11880 | 26.77 |
10:10 ET | 2330 | 26.78 |
10:12 ET | 11786 | 26.755 |
10:14 ET | 9649 | 26.755 |
10:15 ET | 4273 | 26.725 |
10:17 ET | 1958 | 26.745 |
10:19 ET | 18463 | 26.79 |
10:21 ET | 5866 | 26.75 |
10:24 ET | 3993 | 26.745 |
10:26 ET | 1300 | 26.72 |
10:28 ET | 2945 | 26.765 |
10:30 ET | 3230 | 26.75 |
10:32 ET | 4070 | 26.71 |
10:33 ET | 600 | 26.71 |
10:35 ET | 161985 | 26.745 |
10:37 ET | 9630 | 26.77 |
10:39 ET | 9853 | 26.76 |
10:42 ET | 1797 | 26.735 |
10:44 ET | 3212 | 26.73 |
10:46 ET | 2670 | 26.74 |
10:48 ET | 2306 | 26.775 |
10:50 ET | 2517 | 26.7701 |
10:51 ET | 5264 | 26.78 |
10:53 ET | 4820 | 26.755 |
10:55 ET | 6805 | 26.695 |
10:57 ET | 5418 | 26.665 |
11:00 ET | 400 | 26.66 |
11:02 ET | 2846 | 26.665 |
11:04 ET | 2000 | 26.62 |
11:06 ET | 1500 | 26.62 |
11:08 ET | 2602 | 26.62 |
11:09 ET | 2093 | 26.63 |
11:11 ET | 2759 | 26.645 |
11:13 ET | 1752 | 26.64 |
11:15 ET | 1777 | 26.65 |
11:18 ET | 4000 | 26.65 |
11:20 ET | 3100 | 26.63 |
11:22 ET | 5188 | 26.64 |
11:24 ET | 3706 | 26.68 |
11:26 ET | 1000 | 26.665 |
11:27 ET | 3418 | 26.675 |
11:29 ET | 1400 | 26.66 |
11:31 ET | 1538 | 26.65 |
11:33 ET | 700 | 26.65 |
11:36 ET | 16098 | 26.69 |
11:38 ET | 7414 | 26.71 |
11:40 ET | 11353 | 26.79 |
11:42 ET | 6674 | 26.8 |
11:44 ET | 9198 | 26.79 |
11:45 ET | 4790 | 26.79 |
11:47 ET | 1470 | 26.78 |
11:49 ET | 11026 | 26.76 |
11:51 ET | 1726 | 26.78 |
11:54 ET | 2700 | 26.7563 |
11:56 ET | 346 | 26.75 |
11:58 ET | 1488 | 26.755 |
12:00 ET | 2577 | 26.745 |
12:02 ET | 598 | 26.74 |
12:03 ET | 2903 | 26.735 |
12:05 ET | 4368 | 26.725 |
12:07 ET | 4611 | 26.73 |
12:09 ET | 1333 | 26.73 |
12:12 ET | 100 | 26.735 |
12:14 ET | 4104 | 26.755 |
12:16 ET | 5718 | 26.75 |
12:18 ET | 2853 | 26.72 |
12:20 ET | 1200 | 26.72 |
12:21 ET | 26999 | 26.74 |
12:23 ET | 2550 | 26.76 |
12:25 ET | 2647 | 26.7783 |
12:27 ET | 892 | 26.78 |
12:30 ET | 3096 | 26.775 |
12:32 ET | 5976 | 26.76 |
12:34 ET | 400 | 26.75 |
12:36 ET | 2707 | 26.745 |
12:38 ET | 1700 | 26.74 |
12:39 ET | 300 | 26.745 |
12:41 ET | 4072 | 26.735 |
12:43 ET | 9364 | 26.725 |
12:45 ET | 246 | 26.725 |
12:48 ET | 538 | 26.7201 |
12:50 ET | 7422 | 26.715 |
12:52 ET | 2885 | 26.73 |
12:54 ET | 590 | 26.73 |
12:56 ET | 1600 | 26.765 |
12:57 ET | 944 | 26.7699 |
12:59 ET | 700 | 26.765 |
01:01 ET | 1500 | 26.765 |
01:03 ET | 400 | 26.765 |
01:06 ET | 1167 | 26.765 |
01:08 ET | 11057 | 26.785 |
01:10 ET | 8765 | 26.7528 |
01:12 ET | 2469 | 26.76 |
01:14 ET | 1312 | 26.76 |
01:15 ET | 1100 | 26.75 |
01:17 ET | 250 | 26.7502 |
01:19 ET | 400 | 26.755 |
01:21 ET | 7062 | 26.765 |
01:24 ET | 1700 | 26.755 |
01:26 ET | 1031 | 26.7657 |
01:28 ET | 731 | 26.76 |
01:30 ET | 2745 | 26.765 |
01:32 ET | 3297 | 26.77 |
01:33 ET | 11681 | 26.745 |
01:35 ET | 3867 | 26.745 |
01:37 ET | 412 | 26.745 |
01:39 ET | 5980 | 26.76 |
01:42 ET | 1749 | 26.8 |
01:44 ET | 5130 | 26.8 |
01:46 ET | 1440 | 26.81 |
01:48 ET | 4075 | 26.815 |
01:50 ET | 2116 | 26.82 |
01:51 ET | 1037 | 26.815 |
01:53 ET | 1438 | 26.815 |
01:55 ET | 1102 | 26.815 |
01:57 ET | 2713 | 26.8276 |
02:00 ET | 7179 | 26.8 |
02:02 ET | 1187 | 26.7801 |
02:04 ET | 3066 | 26.785 |
02:06 ET | 11016 | 26.79 |
02:08 ET | 852 | 26.7912 |
02:09 ET | 1203 | 26.8035 |
02:11 ET | 879 | 26.803 |
02:13 ET | 6201 | 26.81 |
02:15 ET | 3596 | 26.8009 |
02:18 ET | 1082 | 26.82 |
02:20 ET | 3481 | 26.82 |
02:22 ET | 2710 | 26.82 |
02:24 ET | 8648 | 26.84 |
02:26 ET | 3657 | 26.84 |
02:27 ET | 9485 | 26.84 |
02:29 ET | 3992 | 26.825 |
02:31 ET | 600 | 26.825 |
02:33 ET | 4792 | 26.83 |
02:36 ET | 2600 | 26.825 |
02:38 ET | 11376 | 26.82 |
02:40 ET | 1207 | 26.815 |
02:42 ET | 3407 | 26.815 |
02:44 ET | 3533 | 26.825 |
02:45 ET | 3991 | 26.84 |
02:47 ET | 4194 | 26.85 |
02:49 ET | 8383 | 26.83 |
02:51 ET | 2400 | 26.835 |
02:54 ET | 1051 | 26.835 |
02:56 ET | 12312 | 26.8248 |
02:58 ET | 1056 | 26.825 |
03:00 ET | 4033 | 26.825 |
03:02 ET | 5884 | 26.825 |
03:03 ET | 6314 | 26.875 |
03:05 ET | 4341 | 26.885 |
03:07 ET | 6025 | 26.91 |
03:09 ET | 11863 | 26.92 |
03:12 ET | 4577 | 26.925 |
03:14 ET | 12521 | 26.91 |
03:16 ET | 4253 | 26.87 |
03:18 ET | 5725 | 26.8801 |
03:20 ET | 948 | 26.885 |
03:21 ET | 2094 | 26.885 |
03:23 ET | 5300 | 26.855 |
03:25 ET | 4786 | 26.84 |
03:27 ET | 2601 | 26.86 |
03:30 ET | 5098 | 26.86 |
03:32 ET | 6823 | 26.875 |
03:34 ET | 5154 | 26.875 |
03:36 ET | 2726 | 26.875 |
03:38 ET | 2048 | 26.875 |
03:39 ET | 11651 | 26.865 |
03:41 ET | 9865 | 26.885 |
03:43 ET | 8271 | 26.87 |
03:45 ET | 8558 | 26.85 |
03:48 ET | 6438 | 26.86 |
03:50 ET | 9756 | 26.86 |
03:52 ET | 16846 | 26.885 |
03:54 ET | 21289 | 26.89 |
03:56 ET | 49248 | 26.895 |
03:57 ET | 10621 | 26.895 |
03:59 ET | 37830 | 26.91 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.1B | 15.1x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -11.8x | --- |
Catalent Inc | 10.2B | -8.7x | --- |
Jazz Pharmaceuticals PLC | 6.8B | 22.3x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.5B | 16.6x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.1B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.12% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.1x |
Price/Sales (TTM) | 7.2 |
Price/Cash Flow (TTM) | 13.5x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.